Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HYPATIA trial of hydroxychloroquine to improve pregnancy outcomes in women with antiphospholipid antibodies
2016-002256-25Phase 3Unknown
- Sponsor
- Guy's and St Thomas' NHS Foundation Trust
- Start
- May 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of hydroxychloroquine in antiphospholipid syndrome (APS) (2 arms), sponsored by Guy's and St Thomas' NHS Foundation Trust. Status: unknown.
02
Drugs
hydroxychloroquine
03
Conditions
antiphospholipid syndrome (APS)
Beyond the preview
Go deeper on 2016-002256-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-002256-25.